Clinical Trials Browser

Unknown × Brain Neoplasms × osimertinib × Clear all

NCT02736513 2021-09-02

Intracranial Activity of AZD9291 (TAGRISSO) in Advanced EGFRm NSCLC Patients With Asymptomatic Brain Metastases

Phase 2 Unknown

Brain Neoplasms, Lung Neoplasms

NCT02972333 2016-11-23

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Phase 3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung